News & Updates

Show Multimedia Only

Does UPF intake affect semen quality in men?

13 Aug 2025 by

Consumption of ultra-processed food (UPF) does not appear to influence semen quality parameters among men attending a fertility clinic, suggests a study presented at ESHRE 2025.

Does UPF intake affect semen quality in men?

13 Aug 2025

Microplastics present in human reproductive fluids

12 Aug 2025 by

Data presented at ESHRE 2025 indicate the presence of microplastics (MPs) in follicular and seminal fluids, underscoring concerns about their potential impact on reproductive health.

Microplastics present in human reproductive fluids

12 Aug 2025

Antibiotics use after RARC lowers 90-day UTIs, complications

07 Aug 2025 by

The use of antibiotic therapy for 30 days following robot-assisted radical cystectomy (RARC) results in reduced 90-day urinary tract infections (UTIs), infectious complications, UTI-related readmissions, and costs without an increase in adverse events (AEs), a study has shown.

Antibiotics use after RARC lowers 90-day UTIs, complications

07 Aug 2025

Pegcetacoplan delivers in rare CMKDs causing nephrotic-range proteinuria

29 Jul 2025 by

In patients with either C3G or primary IC-MPGN presenting with nephrotic-range proteinuria, treatment with pegcetacoplan reduces proteinuria and C3c renal biopsy staining and stabilizes kidney function, according to results from a post hoc analysis of VALIANT presented at ERA 2025

Pegcetacoplan delivers in rare CMKDs causing nephrotic-range proteinuria

29 Jul 2025

Behavioural noninferior to drug therapy for OAB symptoms in Parkinson’s disease

27 Jul 2025

In the treatment of overactive bladder (OAB) in patients with Parkinson’s disease (PD), behavioural therapy compares favourably with drug therapy, according to the results of a noninferiority study.

Behavioural noninferior to drug therapy for OAB symptoms in Parkinson’s disease

27 Jul 2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-June-2025

23 Jul 2025

New drug applications approved by US FDA as of 1-15 June 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-June-2025

23 Jul 2025

Which kidney failure patients would benefit most from HDF instead of HD?

22 Jul 2025 by

Younger patients and those with fewer comorbidities benefit most from haemodiafiltration (HDF) instead of conventional haemodialysis (HD), according to a multitrial model presented at ERA 2025.

Which kidney failure patients would benefit most from HDF instead of HD?

22 Jul 2025

Malformation risks higher among infants exposed in utero to TMP-SMX vs beta-lactams

18 Jul 2025

First-trimester exposure to trimethoprim-sulfamethoxazole (TMP-SMX) poses a much higher risk of severe cardiac malformation and cleft lip and palate, among others, when compared with exposure to beta-lactam antibiotics during the same period, according to a study.